Clinical Trial Update: Application of Radiomics-based AI Models in Predicting Clinical Outcome of Patients With Renal Cell Carcinoma After Surgical Treatment

View source ↗

Summary

A clinical trial is evaluating radiomics-based AI models to predict outcomes in renal cell carcinoma patients after surgery. The study is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Snippet

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Conditions: Renal Cell Carcinoma (Kidney Cancer) | Status: RECRUITING